Wynn Capital’s Pfizer PFE Stock Holding History

Wynn Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$763K	Buy	31,704 +85	+0.3%	+$2.22K	0.34%	57
2026 Q1	$888K	Buy	31,619 +720	+2%	+$19.2K	0.46%	53
2025 Q4	$769K	Sell	30,899 -6,360	-17%	-$160K	0.37%	58
2025 Q3	$949K	Buy	37,259 +820	+2%	+$20.2K	0.46%	52
2025 Q2	$883K	Buy	36,439 +160	+0.4%	+$3.73K	0.47%	52
2025 Q1	$919K	Buy	36,279 +14,220	+64%	+$372K	0.55%	48
2024 Q4	$585K	Sell	22,059 -955	-4%	-$25.9K	0.37%	60
2024 Q3	$666K	Buy	23,014 +2,000	+10%	+$58.3K	0.44%	58
2024 Q2	$588K	Buy	21,014 +1,285	+7%	+$35.4K	0.43%	56
2024 Q1	$547K	Sell	19,729 -1,694	-8%	-$47K	0.42%	59
2023 Q4	$617K	Buy	+21,423	New	+$648K	0.5%	52

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wynn Capital's PFE Position: Q2 2026 in Review

Wynn Capital increased its Pfizer (PFE) stake by 0.27% in Q2 2026, buying an estimated $2.22K and bringing the position to 31,704 shares worth $763K. The position accounts for 0.34% of the portfolio, ranked #57.

Wynn Capital first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $949K in Q3 2025. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Wynn Capital held 31,704 shares of Pfizer worth $763K as of Q2 2026.
Wynn Capital bought 85 Pfizer shares in Q2 2026, an estimated $2.22K.
Pfizer made up 0.34% of Wynn Capital's portfolio in Q2 2026, its #57 holding.
Wynn Capital first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Wynn Capital's Pfizer position peaked at $949K in Q3 2025.
1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wynn Capital's 13F filing for Q2 2026, filed 8 Jul 2026.